GENESIS HEALTHCARE REPORTS SOLID FOURTH QUARTER AND YEAR END 2019 RESULTS

NEXT STORY
Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Highlights
PREV STORY
CytomX Therapeutics Announces New Employment Inducement Grant
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF

author_avatar
NASDAQ Market News

Dupixent® (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in children’s lung function in a randomized Phase 3 trial

author_avatar
NASDAQ Market News

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

author_avatar
NASDAQ Market News